Literature DB >> 27450063

Update on primary PCI for patients with STEMI.

Michael P Thomas1, Eric R Bates2.   

Abstract

Primary PCI is the dominant reperfusion strategy for patients with ST-elevation myocardial infarction and continues to evolve. The purpose of this review is to summarize recent reports that focused on the relationship of door-to-balloon time with mortality, radial versus femoral artery access, aspiration thrombectomy, culprit versus multivessel primary PCI, drug-eluting stents, and anticoagulation and antiplatelet therapies.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Coronary artery disease; Myocardial infarction; Percutaneous coronary intervention

Mesh:

Substances:

Year:  2016        PMID: 27450063     DOI: 10.1016/j.tcm.2016.06.010

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  4 in total

Review 1.  Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: a meta-analysis of randomized controlled trials.

Authors:  Lulu Liu; Bin Liu; Jiajun Ren; Gang Hui; Chao Qi; Junnan Wang
Journal:  BMC Cardiovasc Disord       Date:  2018-03-02       Impact factor: 2.298

2.  The association between CRP / Albumin ratio and in-stent restenosis development in patients with ST-segment elevation myocardial infarction.

Authors:  Uğur Aksu; Oktay Gulcu; Emrah Aksakal; Kamuran Kalkan; Mustafa Öztürk; Ali Fuat Korkmaz; Abdulkadir Uslu; Selami Demirelli
Journal:  J Clin Lab Anal       Date:  2019-02-08       Impact factor: 2.352

3.  Long-term outcomes of delayed percutaneous coronary intervention for patients with ST-segment elevation myocardial infarction: A propensity score-matched retrospective study.

Authors:  Yu-Long Xue; Yue-Teng Ma; Yu-Ping Gao; Sheng-Xiao Zhang; Qin-Yi Su; Yu-Feng Li; Lei Zhang; Peng-Fei Ding; Xue-Wen Li
Journal:  Medicine (Baltimore)       Date:  2021-11-19       Impact factor: 1.889

4.  Improved Cardiac Function and Attenuated Inflammatory Response by Additional Administration of Tirofiban during PCI for ST-Segment Elevation Myocardial Infarction Patients.

Authors:  Jing Zhang; Guomin Ding
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-16       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.